Yuria Akira

Clinical Study of Bullous Pemphigoid With Oral Mucosal Symptoms After Oral Administration of Dipeptidyl Peptidase‐4 Inhibitors

ABSTRACT Dipeptidyl peptidase‐4 (DPP‐4) inhibitors are widely used for diabetes treatment. However, reports of DPP‐4 inhibitor‐associated bullous pemphigoid (BP) have been increasing. This study examined 12 cases of BP with oral mucosal lesions associated with DPP‐4 inhibitor the...